Drug Type Small molecule drug |
Synonyms KAN0440550 |
Target |
Action antagonists |
Mechanism ROR1 antagonists(Inactive tyrosine-protein kinase transmembrane receptor ROR1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | Sweden | - | |
Lymphoma | Preclinical | Sweden | - | |
Neoplasms | Preclinical | Germany | - |